Fibromyalgia is described as diffuse musculoskeletal pain with no identifiable structural source, with the diagnostic criteria centred on widespread pain, tender point sensitivity, fatigue, and cognitive disturbance. Standard management includes amitriptyline, duloxetine, graded exercise, and cognitive behavioural therapy — all directed at central sensitisation and pain modulation. These interventions accept that there is no peripheral source for the pain and that the nervous system has become dysregulated centrally. Afferentology challenges the premise: the nervous system is not randomly dysregulated. It is responding logically to multiple afferent irritants that have been simultaneously suppressing muscular tone across multiple cord levels. The result is a global withdrawal reflex pattern — a system-wide reduction in motor neuron output that produces diffuse weakness, tenderness, and pain sensitivity as its clinical expression.
The fibromyalgia patient does not have no peripheral source. They have multiple peripheral sources, each individually subclinical, each contributing a withdrawal reflex withdrawal at its relevant cord level, and all operating simultaneously to produce a global reduction in the 50Hz resting tone that should be running throughout the musculoskeletal system. The nervous system is not broken. It is responding rationally to an aggregate afferent load that it is interpreting as a pervasive threat. The tender points that constitute the fibromyalgia diagnostic picture are the areas where the global reduction in muscle tone is most mechanically exposed — where reduced tone has allowed the passive structures to absorb load that the muscles are no longer adequately managing. The tenderness is not central sensitisation creating pain from nothing; it is peripheral structures under abnormal mechanical stress because their muscular protection has been neurologically withdrawn.
Global Withdrawal: The Aggregate Afferent Load Model
The 50Hz resting tone that the spinal cord maintains in the musculoskeletal system requires a baseline level of afferent input that is mechanically normal. When afferent input from any part of the body signals threat — through nociception, inflammatory mediators, or abnormal mechanoreceptor activity — the spinal cord responds with withdrawal reflex activity at the appropriate cord level. A single afferent irritant produces a localised withdrawal reflex. Multiple simultaneous afferent irritants — each individually minor, collectively significant — produce withdrawal reflex activity across multiple cord levels simultaneously. The total motor neuron output to the musculoskeletal system is reduced. The overall 50Hz resting tone is depressed. The patient experiences this as diffuse weakness, diffuse tenderness, and diffuse pain — not because the nervous system has malfunctioned, but because it is doing exactly what a nervous system should do when it is detecting simultaneous threat signals from multiple body regions.
The standard diagnosis of fibromyalgia as a central sensitisation syndrome is not wrong — the central sensitisation is real, measurable, and clinically significant. But central sensitisation is itself a consequence of prolonged, high-volume afferent input to the central nervous system. Remove the peripheral afferent sources that are maintaining the high afferent load, and the central sensitisation has no incoming signal to sustain it. The nervous system, no longer detecting widespread threat, begins to normalise its motor output. The resting tone recovers. The tender points are no longer mechanically stressed. The pain resolves — not because central pain processing was directly treated, but because the peripheral sources that were driving it were identified and removed.
"Fibromyalgia is not a central nervous system malfunction. It is a central nervous system responding with remarkable consistency to a high, multi-source afferent load. The nervous system has not gone wrong. It has gone into global withdrawal. Find the sources that are driving the withdrawal, and the system has a reason to come out of it."
What Is Driving the Global Inhibition
The multiple afferent irritants that most commonly constitute the aggregate load in fibromyalgia patients include:
- Multiple surgical scars at different body regions: A patient with a history of multiple surgeries — appendicectomy, hysterectomy, knee replacement, Caesarean section, shoulder surgery — may have three, four, or more mature scars, each generating withdrawal reflex activity at its relevant cord level. The aggregate mechanoreceptor output from multiple scars across multiple cord levels produces a global withdrawal reflex pattern that is indistinguishable from the fibromyalgia clinical picture. Systematically challenging each scar and mapping its contribution to the global inhibition pattern is the primary PMT task in this presentation.
- Chronic subclinical infections and inflammatory afferents: Chronic low-grade infections — Epstein-Barr reactivation, chronic Lyme disease, persistent viral infections — generate continuous nociceptive and inflammatory afferent input from affected tissues. This input arrives at the cord through somatic and visceral afferent pathways and adds to the aggregate afferent load that is driving the global withdrawal reflex. Many fibromyalgia patients report that their symptoms began following a viral illness — this history is consistent with the infection generating an acute, high-volume afferent load that initiated the global withdrawal reflex pattern.
- Dental and craniofacial afferents: Occlusal asymmetry, temporomandibular dysfunction, and dental pathology generate trigeminal afferent input that compounds the aggregate load via the trigeminal-cervical complex and its projections to the upper thoracic cord. In fibromyalgia patients with prominent craniofacial symptoms — headache, jaw pain, facial tenderness — dental afferents are a likely contributor to the global afferent load.
- Visceral afferents from irritable bowel and bladder dysfunction: Visceral hyperalgesia — increased sensitivity of the gastrointestinal and urinary afferent systems — is a recognised comorbidity of fibromyalgia. The visceral afferents from the bowel and bladder arrive at the thoracic and lumbar cord segments through the sympathetic chain, adding continuous visceral afferent input to the aggregate load. Managing the visceral component — through dietary modification, gut microbiome support, or visceral afferent challenge — is a necessary component of reducing the global afferent burden in fibromyalgia.
The Software Test: Precision Muscle Testing
PMT in fibromyalgia is a full-body neurological audit — testing the motor neuron supply to major muscle groups across all cord levels and mapping the global inhibition pattern. The result is not a single source identification but an inhibition map that identifies which cord levels are most suppressed and guides the systematic search for the afferent sources contributing to each. Candidate sources are then challenged in order of their clinical significance: surgical scars are challenged first (they are the most consistently present and most potent single sources); visceral and dental afferents are challenged next; chronic infection afferents are challenged where the clinical history supports them.
In fibromyalgia patients, the PMT assessment typically reveals multiple inhibition patterns across multiple cord levels — confirming the aggregate afferent load model. Each source identification and challenge produces a partial restoration of motor neuron output across the affected cord levels. When multiple sources have been identified and addressed, the cumulative restoration of motor neuron output produces a measurable improvement in global muscle tone, a reduction in tender point sensitivity, and an improvement in fatigue and cognitive function — reflecting the nervous system's response to a reduced aggregate afferent load.
Clinical Takeaways
- Fibromyalgia is not a diagnosis of exclusion — it is a diagnosis of inclusion: Instead of excluding structural causes and concluding there are none, PMT identifies the multiple afferent sources that are present and contributing to the aggregate load. The condition has a peripheral basis; it has multiple peripheral bases, each individually subclinical.
- The surgical history is the primary clinical focus in fibromyalgia assessment: Multiple scars across multiple cord levels are the single most consistent finding in fibromyalgia patients assessed with PMT. Documenting every surgical procedure, every significant trauma, and every scar — regardless of its size or apparent significance — is the most important initial step in the neurological assessment.
- Central sensitisation is a consequence of peripheral afferent load, not an independent primary pathology: Reducing the peripheral afferent load through systematic source identification and removal addresses the central sensitisation at its origin. Pharmacological central sensitisation management without peripheral source reduction is managing a consequence while the driver continues.
- The recovery trajectory in fibromyalgia is proportional to the number of sources identified and addressed: A patient with two identifiable afferent sources will improve more rapidly than a patient with six. The clinical objective is to identify and address as many contributing sources as possible, in order of their estimated contribution to the aggregate afferent load. Each source successfully addressed produces a measurable increment of improvement.
Fibromyalgia is not a mystery diagnosis. It is a nervous system in global withdrawal from an aggregate afferent load that has never been systematically mapped.
Map the sources. Address them in order. The nervous system does not want to be in global withdrawal — it is responding to what it is receiving. Change what it is receiving, and it changes what it outputs. The pain, the fatigue, the cognitive fog — they are all downstream of the motor neuron withdrawal. Restore the motor neurons, and the downstream normalises.